咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Activity of Angiogenesis Inhib... 收藏

Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma:A Case Report

Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma:A Case Report

作     者:Sumit Gaur Alireza Torabi Thomas I O'Neill 

作者机构:Divisions of Hematology-OncologyTexas Tech University Health Science Center Divisions of Pathology Texas Tech University Health Science Center Divisions of RadiologyTexas Tech University Health Science Center 

出 版 物:《Clinical oncology and cancer researeh》 (Cancer Biol. Med.)

年 卷 期:2012年第9卷第2期

页      面:133-136页

核心收录:

学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主  题:hemangioendothelioma angiogenesis inhibitors nab-paclitaxel bevacizumab 

摘      要:This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound *** treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid *** describing the activity of bevacizumab and other agents(thalidomide,lenalidomide,and interferon) believed to possess anti-angiogenic activities is also reviewed.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分